FdaApplication
ANDA 212198
Identifiers
- fda_app_no: ANDA212198
Properties
| Property | Value |
|---|---|
| applicant_name | ZYDUS PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2022-07-07 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 12.5MG;500MG | TABLET;ORAL |
| EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 5MG;500MG | TABLET;ORAL |
| EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 12.5MG;1GM | TABLET;ORAL |
| EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 5MG;1GM | TABLET;ORAL |
4 products